Product Information

QUETIAPINE ER 300 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.2347 per EA under NDC 68001060106. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Aug 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE ER 300 MG TABLET

Quetiapine
$0.2347per EA

Strength

300 mg/1

NDC

68001060106

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215478

FDA Approved

8/15/2022

TE Code

AB

On Market Since

11/1/2023

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE ER 300 MG TABLET has been published 154 times since Dec 13, 2023, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2347 per EA
All-time high$0.3119 (Apr 10, 2024)
All-time low$0.1954 (Nov 20, 2024)
52-week high$0.2805
52-week low$0.2347
Median price$0.2701
Average price$0.2669
Largest weekly change+47.7% (Aug 21, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

-8.2%

1M

-13.6%

3M

-15.1%

6M

-12.5%

1Y

-13.1%

3Y

N/A

5Y

N/A

All

-12.8%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QUETIAPINE ER 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by BluePoint Laboratories, is $0.2347 per EA (NDC 68001060106), effective Nov 18, 2026.

How has the price of QUETIAPINE ER 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has declined 12.8%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?

Since Dec 13, 2023, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $0.3119 (Apr 10, 2024), with a median of $0.2701 per EA.

Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1330 per EA — about 43% below QUETIAPINE ER 300 MG TABLET.

Who manufactures QUETIAPINE ER 300 MG TABLET?

QUETIAPINE ER 300 MG TABLET (NDC 68001060106) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.